Plavix 75 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Pharmacodynamic Outcomes in patients with coronary artery disease undergoing Percutaneous coronary intervention treated with an individualized treatment STRATEGY (POPular STRATEGY PD)
This study looks at different blood-thinning medicines for people who have had a heart procedure called a stent. Researchers want to see which medicine works best to prevent blood clots while also checking for any bleeding, to help doctors choose the right treatment for each patient.
For: Stable coronary artery disease · Chronic coronary syndromeNetherlands - Ongoing, recruitingTherapeutic use (Phase IV)
Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)
This study looks at different blood-thinning medicines given after a heart attack to see which combinations best prevent serious problems like another heart attack, stroke, or severe bleeding. It's for adults of all ages, men and women, who have recently had a heart attack.
For: Acute Myocardial InfarctionSpain · Netherlands · Italy - AuthorisedTherapeutic confirmatory (Phase III)
MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study. An international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.
This study, called MOSES, is looking at how best to prevent another stroke in people who have recently had one. It's testing if a specific blood test, together with different blood-thinning medicines, can help doctors choose the best treatment to stop future strokes.
For: Acute ischemic strokeGreece · Spain